These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22873045)

  • 21. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
    Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
    Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of quality-of-life endpoints in clinical trials to the practicing oncologist.
    Passik SD; Kirsh KL
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):877-86. PubMed ID: 10949778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers to participation in clinical trials: a physician survey.
    Mahmud A; Zalay O; Springer A; Arts K; Eisenhauer E
    Curr Oncol; 2018 Apr; 25(2):119-125. PubMed ID: 29719427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are cancer patients better off if they participate in clinical trials? A mixed methods study.
    Engelbak Nielsen Z; Eriksson S; Schram Harsløf LB; Petri S; Helgesson G; Mangset M; Godskesen TE
    BMC Cancer; 2020 May; 20(1):401. PubMed ID: 32384883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement.
    Ligibel JA; Alfano CM; Hershman D; Ballard RM; Bruinooge SS; Courneya KS; Daniels EC; Demark-Wahnefried W; Frank ES; Goodwin PJ; Irwin ML; Levit LA; McCaskill-Stevens W; Minasian LM; O'Rourke MA; Pierce JP; Stein KD; Thomson CA; Hudis CA
    J Clin Oncol; 2015 Nov; 33(33):3961-7. PubMed ID: 26324364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.
    Hurria A; Levit LA; Dale W; Mohile SG; Muss HB; Fehrenbacher L; Magnuson A; Lichtman SM; Bruinooge SS; Soto-Perez-de-Celis E; Tew WP; Postow MA; Cohen HJ;
    J Clin Oncol; 2015 Nov; 33(32):3826-33. PubMed ID: 26195697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can CER be an effective tool for change in the development and assessment of new drugs and technologies?
    Brixner DI; Watkins JB
    J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S06-11. PubMed ID: 22663293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Views of American oncologists about the purposes of clinical trials.
    Joffe S; Weeks JC
    J Natl Cancer Inst; 2002 Dec; 94(24):1847-53. PubMed ID: 12488478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The changing role of the surgical oncologist.
    Cady B
    Surg Clin North Am; 2000 Apr; 80(2):459-69. PubMed ID: 10836001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards a high standard of surgical oncology throughout Europe.
    O'Higgins N
    Eur J Cancer; 1995; 31A Suppl 6():S22-4. PubMed ID: 8534527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer.
    Hussain T; Chang HY; Veenstra CM; Pollack CE
    J Oncol Pract; 2015 May; 11(3):e388-97. PubMed ID: 25873063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A framework for understanding cancer comparative effectiveness research data needs.
    Carpenter WR; Meyer AM; Abernethy AP; Stürmer T; Kosorok MR
    J Clin Epidemiol; 2012 Nov; 65(11):1150-8. PubMed ID: 23017633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Society of Surgical Oncology and the Commission on Cancer: progress through synergism.
    Winchester DP
    Ann Surg Oncol; 1998 Sep; 5(6):483-8. PubMed ID: 9754755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients.
    Felgenhauer J; Hooke MC
    Pediatrics; 2014 Jun; 133 Suppl 3():S119-22. PubMed ID: 24918210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgeon and medical oncologist peer network effects on the uptake of the 21-gene breast cancer recurrence score assay.
    Zipkin R; Schaefer A; Chamberlin M; Onega T; O'Malley AJ; Moen EL
    Cancer Med; 2021 Feb; 10(4):1253-1263. PubMed ID: 33455068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do surgeons decide to refer patients for adjuvant cancer treatment? Protocol for a qualitative study.
    Urquhart R; Kendell C; Sargeant J; Buduhan G; Johnson P; Rayson D; Grunfeld E; Porter GA
    Implement Sci; 2012 Oct; 7():102. PubMed ID: 23098262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rethinking clinical research in surgical oncology. From comic opera to quality control].
    Evrard S
    Bull Cancer; 2016 Jan; 103(1):87-95. PubMed ID: 26610367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.
    Weiner BJ; Jacobs SR; Minasian LM; Good MJ
    J Oncol Pract; 2012 Sep; 8(5):287-91. PubMed ID: 23277765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicians' attitudes to clinical trials of cancer therapy.
    Fallowfield L; Ratcliffe D; Souhami R
    Eur J Cancer; 1997 Nov; 33(13):2221-9. PubMed ID: 9470810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.